Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer

NCT00535015 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

70

Enrollment

INDUSTRY

Sponsor class

Stopped Objectives of study could not be met within a reasonable timeframe.

Conditions

Anorexia
Cachexia
Weight Loss
Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Betamarc

Sponsor

Anaborex